Background Short-term mortality rates among patients with HIV receiving antiretroviral
therapy (ART) in sub-Saharan Africa are higher than those recorded in high-income …

Background HIV antiretroviral therapy (ART) is often managed without routine laboratory
monitoring in Africa; however, the effect of this approach is unknown. This trial investigated …

Objective To analyse the outcomes of antiretroviral therapy (ART) in routine conditions in a
rural hospital in the Far‐North province of Cameroon. Method Retrospective cohort study of …

Background Mortality in HIV-infected patients who have access to highly active antiretroviral
therapy (ART) has declined in sub-Saharan Africa, but it is unclear how mortality compares …

Background Decisions about when to start an antiretroviral therapy (ART) are normally
based on CD4 cell counts and viral load (VL). However, these measurements require …

Background Little is known about how to implement antiretroviral treatment programmes in
resource-limited countries. We assessed the UNAIDS/Uganda Ministry of Health HIV Drug …

Background The World Health Organization (WHO) has recommended guidelines for a HIV
drug resistance (HIVDR) survey for resource-limited countries. Eligibility criteria for patients …

The public sector scale-up of antiretroviral therapy (ART) in South Africa commenced in
2004. We aimed to describe the hospital-level disease burden and factors contributing to …

Background High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in
sub-Saharan Africa, compared to Europe and North America, is well documented. Longer …

Objectives: Highly active antiretroviral therapy (HAART) has been available in government
facilities in the Western Cape Province of South Africa since 2001. We aimed to investigate …